MULTILAYER STRUCTURE
20240271325 ยท 2024-08-15
Inventors
- Alexander AZAROV (Oslo, NO)
- Andrej KUZNETSOV (Oslo, NO)
- Vishukanthan VENKATACHALAPATHY (Oslo, NO)
- Calliope BAZIOTI (Oslo, NO)
Cpc classification
H01L21/02414
ELECTRICITY
C30B33/04
CHEMISTRY; METALLURGY
C30B29/68
CHEMISTRY; METALLURGY
International classification
Abstract
The invention provides a multilayer structure comprising at least two monocrystalline layers A and B, wherein layer A comprises ?-Ga.sub.2O.sub.3 and layer B comprises ?-Ga.sub.2O.sub.3 and wherein layers A and B are adjacent
Claims
1. A multilayer structure comprising at least two monocrystalline layers A and B, wherein layer A comprises ?-Ga.sub.2O.sub.3 and layer B comprises ?-Ga.sub.2O.sub.3 and wherein layers A and B are adjacent.
2. The multilayer structure as claimed in claim 1, wherein the thickness of the layers is in the range of 10 nm to 10 ?m.
3. The multilayer structure as claimed in claim 1, wherein said structure comprises three layers in the order BAB.
4. The multilayer structure as claimed in claim 1, wherein each layer is homogenous.
5. The multilayer structure as claimed in claim 1, wherein the interface between the layers is continuous.
6. A method for producing ?-Ga.sub.2O.sub.3, said method comprising the step of irradiating ?-Ga.sub.2O.sub.3 with an ion beam.
7. The method as claimed in claim 6, wherein said ion beam is a medium to heavy ion beam.
8. The method as claimed in claim 6, wherein said ?-Ga.sub.2O.sub.3 is monocrystalline.
9. The method as claimed in claim 6, wherein said ?-Ga.sub.2O.sub.3 forms a layer in a multilayer structure comprising at least two monocrystalline layers A and B, wherein layer A comprises ?-Ga.sub.2O.sub.3 and layer B comprises ?-Ga.sub.2O.sub.3 and wherein layers A and B are adjacent.
10. The method as claimed in claim 6, wherein the method does not require applying external pressures.
11. The method as claimed in claim 6, wherein the irradiation takes place at room temperature.
12. The method as claimed in claim 6, wherein said ion beam has a dosage of 1?10.sup.13 to 1?10.sup.17 ions cm.sup.?2.
13. A semiconductor device comprising a multilayer structure as claimed in claim 1.
14. A multilayer structure prepared by a method which comprises the step of irradiating a ?-Ga.sub.2O.sub.3 substrate with an ion beam capable of inducing a phase transition.
15. The multilayer structure prepared by a method as claimed in claim 14, wherein said ion beam is a medium to heavy ion beam.
16. The multilayer structure prepared by a method as claimed in claim 14, wherein said ion beam has a dosage of 1?10.sup.13 to 1?10.sup.17 ions cm.sup.?2.
17. The multilayer structure prepared by a method as claimed in claim 14, wherein said ion beam comprises nickel, gallium, or gold ions.
18. The multilayer structure prepared by a method as claimed in claim 17, wherein the nickel, gallium or gold ions are selected from .sup.58Ni.sup.+, .sup.69Ga.sup.+ and .sup.197Au.sup.+.
19. The multilayer structure prepared by a method as claimed in claim 14, wherein the ?-Ga.sub.2O.sub.3 substrate is provided in the form of a (010) or (?201) oriented ?-Ga.sub.2O.sub.3 single crystal wafer.
Description
[0030]
[0031]
[0032]
[0033]
EXAMPLES
[0034] (010) and (?201) oriented ?-Ga.sub.2O.sub.3 single crystal wafers (Tamura Corp.) were implanted with different ions, specifically .sup.58Ni.sup.+, .sup.69Ga.sup.+, and .sup.197Au.sup.+. The ballistic defect production rates (without accounting for non-linear cascade density effects) for .sup.69Ga.sup.+ and .sup.197Au.sup.+ implants were normalized to that of .sup.58Ni.sup.+ ion implanted with 400 keV in a wide dose range of 6?10.sup.13 to 1?10.sup.16 cm.sup.?2. The implantations were performed at room temperature (if not indicated otherwise) and 7? off the normal direction.
[0035] The samples were analyzed by a combination of Rutherford backscattering spectrometry in channeling mode (RBS/C), x-ray diffraction (XRD) and scanning transmission electron microscopy (STEM) combined with electron energy loss spectroscopy (EELS). The RBS/C was performed using 1.6 MeV He.sup.+ ions incident along [010] direction and 1650 backscattering geometry. The XRD 2 theta measurements were performed using Bruker AXS D8 Discover diffractometer using Cu K.sub.?1 radiation in locked-coupled mode.
[0036] The STEM and EELS investigations were conducted on an FEI Titan G2 60-300 kV at 300 kV with a probe convergence angle of 24 mrad. The simultaneous STEM imaging was conducted with 3 detectors: high-angle annular dark field (HAADF) (collection angles 101.7-200 mrad), annular dark field (ADF) (collection angles 22.4-101.7 mrad) and annular bright field (ABF) (collection angles 8.5-22.4 mrad). The resulting spatial resolution achieved was approximately 0.08 nm. EELS was performed using a Gatan Quantum 965 imaging filter. The energy dispersion was 0.1 eV/channel and the energy resolution measured using the full width at half maximum (FWHM) of the zero-loss peak was 1.1 eV. Electron transparent TEM samples with a cross-sectional wedge geometry were prepared by mechanical polishing with the final thinning performed by Ar ion milling and plasma cleaning.
[0037] Formation of the new phase in ?-Ga.sub.2O.sub.3 due to high dose implantation is supported by STEM investigations and
[0038] Moreover, the comparison between EELS spectra in
[0039] The next figure demonstrates that the phenomenon of the ?-to-? phase transition is generically related to the accumulation of the lattice disorder and not to the chemical nature of the implanted ions. This was proved by performing control implants with Ga and Au ions. Note that, the ballistic defect production rates for Ga, and Au implants were normalized to that of Ni ion implanted with 400 keV in a wide dose range of 6?10.sup.13-1?10.sup.16 cm.sup.?2.